☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
MDGH
Medicines Development for Global Health's (MDGH) Moxidectin Receives FDA Approval for Onchocerciasis (River Blindness)
June 13, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.